Dachaigh › Ailseachadh nan Sgamhan › Texas › San Antonio
Sgrùdaidhean clionaigeach Ailseachadh nan Sgamhan ann an San Antonio, TX
Tha 26 sgrùdaidhean airson Ailseachadh nan Sgamhan a’ lorg phàirtichean aig làraichean ann agus timcheall air San Antonio (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study of ZW251 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- START San Antonio, San Antonio
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Audie L Murphy VA Hospital, San Antonio
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
A’ fastadhÌre 1
- University of Texas San Antonio (UTSA), San Antonio
A Study of PHN-012 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1
- PHN-012-001 Site, San Antonio
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
A’ fastadhÌre 2/3
- Local Institution - 0173, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A’ fastadhÌre 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
A’ fastadhÌre 1
- NEXT, San Antonio
- START - San Antonio, San Antonio
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
A’ fastadhÌre 1/2
- START San Antonio, San Antonio
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
A’ fastadhÌre 1
- START - San Antonio, San Antonio
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
A’ fastadhÌre 1/2
- Avenzo Therapeutics Recruiting Site, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
A’ fastadhÌre 1
- START San Antonio, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- UT Health Mays Cancer Center, San Antonio
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- START - San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
A’ fastadhÌre 1
- South Texas Accelerated Research Therapeutics, San Antonio
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
A’ fastadh
- Audie Murphy VA Medical Center, San Antonio
- Brooke Army Medical Center, San Antonio
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
A’ fastadhÌre 1/2
- Mays Cancer Center / University of Texas, San Antonio, San Antonio
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
A’ fastadhÌre 1
- NEXT Oncology, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
A’ fastadhÌre 1
- Research Site #2, San Antonio
- Research Site, San Antonio
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
A’ fastadhÌre 1
- START, San Antonio
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
A’ fastadhÌre 1/2
- NEXT Oncology, San Antonio
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
A’ fastadhÌre 1/2
- Next Oncology, San Antonio
Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
A’ fastadhSgrùdadh amharc
- UT Health San Antonio, M.D. Anderson Cancer Center, San Antonio
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
A’ fastadhÌre 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
- UT Health San Antonio, San Antonio
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
A’ fastadhÌre 1/2
- Next Oncology, San Antonio, San Antonio
Collection of Sputum and Labeling for Lung Cancer
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- South Texas Veterans Health Care System (STVHCS)/Audie L. Murphy Memorial Veterans Hospital, San Antonio
Sgrùdaidhean Ailseachadh nan Sgamhan ann am bailtean eile
- Houston, TX78 sgrùdaidhean
- Boston, MA62 sgrùdaidhean
- New York City, NY60 sgrùdaidhean
- Los Angeles, CA45 sgrùdaidhean
- Arlington, VA41 sgrùdaidhean
- Washington, DC41 sgrùdaidhean
- Chicago, IL41 sgrùdaidhean
- Baltimore, MD40 sgrùdaidhean
- Nashville, TN40 sgrùdaidhean
- St. Louis, MO39 sgrùdaidhean
- Columbus, OH37 sgrùdaidhean
- Philadelphia, PA36 sgrùdaidhean
Sgrùdaidhean eile ann an San Antonio
- Aillse Sgamhain Neo-chealla-beag59 sgrùdaidhean
- Aillse a' bhroilleach47 sgrùdaidhean
- Aillse colorectal46 sgrùdaidhean
- Ailse metastatach44 sgrùdaidhean
- Aillse (gach seòrsa)41 sgrùdaidhean
- Obesity40 sgrùdaidhean
- Diabaitis Seòrsa 237 sgrùdaidhean
- Ro-throm34 sgrùdaidhean
- Cancer Ovarian31 sgrùdaidhean
- Cancer Pancreatic31 sgrùdaidhean
- Aillse Prostata28 sgrùdaidhean
- Ailse Endometrial27 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.